Concepedia

Linda J Kelly

LJ

Statistics

Publications

15

Citations

856

H-Index

13

Active since

1985

Affiliations

University of the West of Scotland(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

NHS Lanarkshire

United States Military Academy

Cancer Research UK

Linda J Kelly is an author at University of the West of Scotland specializing in medicine, patient safety, and vascular surgery.

ORCID

Top concepts

Publications per year

1985–2019

15

Publications

15

Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator

Joel P. Berger, Ann Petro, Karen L. MacNaul et al. · Molecular Endocrinology · 2003 · 321 citations · Full text

, , +17

Evidence-based consensus on the insertion of central venous access devices: definition of minimal requirements for training

Nancy Moureau, Massimo Lamperti, Linda J Kelly et al. · British Journal of Anaesthesia · 2013 · 221 citations · Full text

, , +7

Evidence for Peroxisome Proliferator-Activated Receptor (PPAR)α-Independent Peroxisome Proliferation: Effects of PPARγ/δ-Specific Agonists in PPARα-Null Mice

John G. DeLuca, Thomas W. Doebber, Linda J Kelly et al. · Molecular Pharmacology · 2000 · 53 citations

Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation

Olívia Wu, Kathleen Boyd, Elaine McCartney et al. · British Journal of Cancer · 2016 · 48 citations · Full text

A Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist Demonstrates Favorable Effects on Lipid Homeostasis

Qiu Guo, Soumya P. Sahoo, Pei-Ran Wang et al. · Endocrinology · 2004 · 40 citations · Full text

1–5 of 15